Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Independence OH, North Canton OH, Allentown PA,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase2, Recruiting
Validation of a Salivary miRNA Diagnostic Test for ASD
Get alerts for new trials in your area by subscribing now
Postoperative Pain After Activation of Irrigant
for
Pain
Location: Cleveland OH
Sponsor: Cleveland Dental Institute
Sex: All
Age: 18 - 50
Code: NCT06528574
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Canton OH, Farrell PA, Mansfield OH, New Castle PA,
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
for
Early Alzheimer's Disease
Location: Independence OH, North Canton OH, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07033494
Phase2, Recruiting
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
for
Postoperative Complications, Alcohol Use Disorder
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 21 - 70+
Code: NCT06864819
Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Medina OH, Cleveland OH, London, Ann Arbor MI,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase2, Phase3, Recruiting
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
for
Alzheimer Disease, Psychosis
Location: Independence OH, Gilbert AZ, Chino CA
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06947941
Phase3, Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor